Search Results - "Kattamis, A"

Correction to: Dental caries and dental developmental defects as adverse effects of antineoplastic treatment in childhood cancer survivors by Seremidi, K., Kavvadia, K., Kattamis, A., Polychronopoulou, A.

Get full text

Dental caries and dental developmental defects as adverse effects of antineoplastic treatment in childhood cancer survivors by Seremidi, K., Kavvadia, K., Kattamis, A., Polychronopoulou, A.

“…Purpose To evaluate the prevalence of dental caries and dental developmental defects (DDD) in childhood cancer survivors (CCS) and identify disease and…”
Get full text

Insights from the Greek experience of the use of Blinatumomab in pediatric relapsed and refractory acute lymphoblastic leukemia patients by Ampatzidou, M, Kattamis, A, Baka, M, Paterakis, G, Anastasiou, T, Tzanoudaki, M, Kaisari, A, Avgerinou, G, Doganis, D, Papadakis, V, Kitra, V, Polychronopoulou, S

“…Pediatric refractory or relapsed acute lymphoblastic leukemia (ALL) poses unique therapeutic challenges, with novel immunotherapy approaches offering potential…”
Get more information

PB2231: RATIONALE FOR THE USE OF COMBINATION CHELATION THERAPY IN PATIENTS WITH THALASSEMIA SYNDROMES OR SICKLE CELL ANEMIA: A SYSTEMATIC LITERATURE REVIEW by Kattamis, A., Kwiatkowski, J., Tricta, F., Igboekwe, E., Fradette, C., Piga, A., Sheth, S.

Get full text

P1511: EFFICACY AND SAFETY OF COMBINATION IRON CHELATION THERAPY WITH DEFERIPRONE AND DEFERASIROX IN PATIENTS WITH Β‐THALASSEMIA MAJOR: A SYSTEMATIC LITERATURE REVIEW by Piga, A., Sheth, S., Kattamis, A., Tricta, F., Igboekwe, E., Fradette, C., Kwiatkowski, J.

Get full text

IMPROVEMENTS IN FATIGUE AND 6-MINUTE WALK TEST IN ADULTS WITH ALPHA- OR BETA-NON–TRANSFUSION-DEPENDENT THALASSEMIA: THE PHASE 3 ENERGIZE TRIAL OF MITAPIVAT by KH Kuo, H Al-Samkari, Y Aydinok, M Besser, S Gheuens, G Luna, A Glenthj, AS Goh, A Kattamis, SR Loggetto, KM Musallam, P Ricchi, E Salido-Fiérrez, S Sheth, V Viprakasit, MD Cappellini, AT Taher

“…Background: Thalassemia, a group of inherited disorders characterized by ineffective erythropoiesis and chronic hemolytic anemia, is associated with…”
Get full text

ENERGIZE: A GLOBAL PHASE 3 STUDY OF MITAPIVAT DEMONSTRATING EFFICACY AND SAFETY IN ADULTS WITH ALPHA- OR BETA-NON–TRANSFUSION-DEPENDENT THALASSEMIA by AT Taher, H Al-Samkari, Y Aydinok, M Besser, G Luna, S Gheuens, A Glenthj, AS Goh, A Kattamis, SR Loggetto, KM Musallam, P Ricchi, E Salido-Fiérrez, S Sheth, V Viprakasit, MD Cappellini, KH Kuo

“…Background: In thalassemia, ATP production in erythroid cells is too low to meet the demand of oxidative stress and ensuing cellular damage; this leads to…”
Get full text

S124: ADVERSE EVENTS FOLLOWING COVID‐19 VACCINATION IN TRANSFUSION‐DEPENDENT ‐THALASSEMIA PATIENTS by Delaporta, P, Kyriakopoulou, D, Ioakeimidou, N, Solomou, E, Binenbaum, I, Toutoudaki, K, Chatzielefteriou, M, Papassotiriou, I, Kattamis, A

Get full text

Twenty-one additional cases of familial renal glucosuria: absence of genetic heterogeneity, high prevalence of private mutations and further evidence of volume depletion by Calado, Joaquim, Sznajer, Yves, Metzger, Daniel, Rita, Ana, Hogan, Marie C., Kattamis, Antonis, Scharf, Mauro, Tasic, Velibor, Greil, Johann, Brinkert, Florian, Kemper, Markus J., Santer, René

“…Introduction. Familial renal glucosuria (FRG) is a rare renal tubular disorder caused by mutations within the SLC5A2 gene. It is characterized by persistent…”
Get full text

Stability of amorphous-silicon TFTs deposited on clear plastic substrates at 250 °C to 280 ° C by LONG, K, KATTAMIS, A. Z, CHENG, I.-C, GLESKOVA, H, WAGNER, S, STURM, J. C

Get full text

P1506: REAL‐WORLD DATA ON THE USE OF LUSPATERCEPT IN GREEK PATIENTS WITH TRANSFUSION DEPENDENT THALASSEMIA by Delaporta, P., Delicou, S., Kouraklis‐Symeonidis, A., Diamantidis, M., Vlachaki, E., Xydaki, A., Labropoulou, V., Lazaris, V., Michalitsis, M., Klonizakis, P., Toutoudaki, K., Chatzieleftheriou, M.‐I., Kyriakopoulou, D., Kattamis, A.

Get full text

P1517: REAL‐WORLD COMPLICATION BURDEN AND DISEASE MANAGEMENT IN TRANSFUSION‐DEPENDENT ADULTS WITH ΒETA‐THALASSEMIA (Β‐THAL) IN GREECE: FINAL RESULTS OF THE EPIDEMIOLOGICAL CROSS‐SECTIONAL ULYSSES STUDY by Kattamis, A., Voskaridou, E., Delicou, S., Klironomos, E., Lafiatis, I., Petropoulou, F., Diamantidis, M. D., Lafioniatis, S., Evliati, L., Kapsali, E., Karvounis‐Marolachakis, K., Timotheatou, D., Deligianni, C., Viktoratos, P., Kourakli, A.

Get full text

P1521: A SEVERE MOUSE MODEL OF ALPHA‐THALASSEMIA SHOWS ABNORMAL IRON METABOLISM, ERYTHROPOIESIS AND COAGULATION, AND CAN BE RESCUED BY A NOVEL GENE THERAPY APPROACH by Rivella, S., Chappell, M., Jarocha, D., Breda, L., Ghiaccio, V., Fedorky, M., Triebwasser, M., Guerra, A., Gollomp, K., Teawtrakul, N., Glentis, S., Kattamis, A., Abdulmalik, O.

Get full text

5612617 EFFICACY AND SAFETY OF A SINGLE DOSE OF EXAGAMGLOGENE AUTOTEMCEL FOR TRANSFUSION‐DEPENDENT‐THALASSEMIA AND SEVERE SICKLE CELL DISEASE by Fuente, J., Locatelli, F., Frangoul, H., Corbacioglu, S., Wall, D., Cappellini, M., Montalembert, M., Kattamis, A., Lobitz, S., Rondelli, D., Sheth, S., Steinberg, M., Walters, M., Bobruff, Y., Simard, C., Song, Y., Zhang, L., Sharma, A., Imren, S., Hobbs, B., Grupp, S.

Get full text

P112: ENERGIZE AND ENERGIZE‐T: TWO PHASE 3, RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON‐‐TRANSFUSION‐DEPENDENT OR TRANSFUSION‐DEPENDENT ALPHA‐ OR BETA‐THALASSEMIA by Kuo, K, Layton, D, Al‐Samkari, H, Kattamis, A, Sheth, S, Taher, A, Viprakasit, V, Chamberlain, C, Czapla, L, Gheuens, S, Lynch, M, Tong, B, Uhlig, K, Cappellini, M

Get full text

S104: A SEVERE MOUSE MODEL OF ALPHA‐THALASSEMIA SHOWS ABNORMAL IRON METABOLISM, ERYTHROPOIESIS AND COAGULATION, AND CAN BE RESCUED BY A NOVEL GENE THERAPY APPROACH by Chappell, M, Breda, L, Guerra, A, Ghiaccio, V, Fedorky, M, Jarocha, D, Gollomp, K, Teawtrakul, N, Glentis, S, Kattamis, A, Rivella, S

Get full text

P1507: CLINICAL PROFILE OF COVID‐19 INFECTION AND IMMUNE RESPONSE AFTER 3AND6 MONTH VACCINATION AGAINST SARS‐COV‐2 IN ADULT PATIENTS WITH TRANSFUSION‐DEPENDENT THALASSAEMIA‐THE EXPERIENCE OF A GREEK CENTER by Delaporta, P., Terpos, E., Solomou, E. E., Gumeni, S., Chatzielefteriou, M.‐I., Toutoudaki, K., Kyriakopoulou, D., Ioakeimidou, N., Ntanasis‐Stathopoulos, I., Papassotiriou, I., Trougakos, I. P., Dimopoulos, M. A., Kattamis, A.

Get full text

PB1914: CYTOGENETIC FINDINGS IN 18 CHILDREN WITH MYELODYSPLASTIC SYNDROMES BY KARYOTYPIC AND FISH ANALYSIS by Manola, K., Diamantopoulou, P., Kelaidi, C., Petrikkos, L., Ioannidou, T., Stefanaki, K., IOANNIDOU, E., Tourkantoni, N., Tsitsikas, K., Kourti, M., Antoniadi, K., Dana, E., Pelagiadis, I., Mantadakis, E., Economou, M., Makis, A., Papakonstantinou, E., Kosmidis, H., Stiakaki, E., Paterakis, G., Kattamis, A., Peristeri, I., Pantelia, D., Margariti, M. I., Nakopoulos, P., Sambani, C., Polychronopoulou, S.

Get full text

P1518: LONG‐TERM SAFETY RESULTS OF THE BELIEVE STUDY OF LUSPATERCEPT IN ADULTS WITH ΒETA‐THALASSEMIA by Viprakasit, V., Cappellini, M. D., Porter, J. B., Kuo, K. H. M., Coates, T. D., Voskaridou, E., Pinto, V. M., Tartaglione, I., Khelif, A., Lal, A., Kattamis, A., Piga, A., Hermine, O., Holot, N., Lersch, F., Shetty, J. K., Zhang, J., Bueno, L., Giuseppi, A. C., Miteva, D., Taher, A. T.

Get full text

S270: LONGER‐TERM ANALYSIS OF EFFICACY OF LUSPATERCEPT VERSUS PLACEBO IN PATIENTS WITH TRANSFUSION‐DEPENDENT BETA‐THALASSEMIA ENROLLED IN THE BELIEVE STUDY by Cappellini, M. D., Taher, A. T., Porter, J. B., Kuo, K. H., Coates, T. D., Voskaridou, E., Forni, G. L., Perrotta, S., Khelif, A., Lal, A., Kattamis, A., Piga, A., Hermine, O., Holot, N., Lersch, F., Shetty, J. K., Vodala, S., Zhang, J., Miteva, D., Viprakasit, V.

Get full text